Catalyst Wire Dossier Catalyst Wire Dossier

BRENZAVVY

BEXAGLIFLOZIN · TheracosBio, LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BRENZAVVY, covering 2023-01-20 to 2023-09-12. Get the full timeline:

Most recent: FDA Approved: BRENZAVVY — Supplemental Application (TheracosBio, LLC)

See pricing